Comerica Bank’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$812K Sell
20,285
-943
-4% -$38.9K 0.01% 1569
2022
Q3
$800K Buy
21,228
+3,997
+23% +$140K 0.01% 1579
2022
Q2
$616K Sell
17,231
-82
-0.5% -$2.66K 0.01% 1752
2022
Q1
$658K Buy
17,313
+636
+4% +$21.8K ﹤0.01% 1763
2021
Q4
$543K Sell
16,677
-1,006
-6% -$42K ﹤0.01% 1838
2021
Q3
$827K Sell
17,683
-26,140
-60% -$1.17M 0.01% 1764
2021
Q2
$2.03M Sell
43,823
-287
-0.7% -$11.1K 0.01% 1302
2021
Q1
$1.62M Buy
44,110
+2,515
+6% +$94.6K 0.01% 1481
2020
Q4
$1.79M Buy
41,595
+3,893
+10% +$146K 0.01% 1368
2020
Q3
$1.34M Sell
37,702
-1,021
-3% -$36.9K 0.01% 1378
2020
Q2
$1.42M Buy
38,723
+1,278
+3% +$34.8K 0.01% 1307
2020
Q1
$898K Sell
37,445
-1,004
-3% -$22.4K 0.01% 1416
2019
Q4
$893K Buy
38,449
+944
+3% +$20.6K 0.01% 1626
2019
Q3
$795K Buy
+37,505
New +$739K 0.01% 1656

Other funds holding GMAB

Comerica Bank's GMAB Position: Q4 2022 in Review

Comerica Bank reduced its Genmab (GMAB) stake by 4.4% in Q4 2022, selling an estimated $38.9K and leaving 20,285 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #1569.

Comerica Bank first reported a position in GMAB in Q3 2019 and has held it in 14 quarters since. The position peaked at $2.03M in Q2 2021. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

  • Comerica Bank held 20,285 shares of Genmab worth $812K as of Q4 2022.
  • Comerica Bank sold 943 Genmab shares in Q4 2022, an estimated $38.9K.
  • Genmab made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1569 holding.
  • Comerica Bank first reported a position in Genmab in Q3 2019 and has held it in 14 quarters since.
  • Comerica Bank's Genmab position peaked at $2.03M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.